Keywords: Pancreas, Cancer, DCE-MRI, Pancreatic cancer, Therapy monitoring, Perfusion phantom, QuantificationDynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measures tissue perfusion by monitoring the dynamic change of MRI contrast agents. However, the inter/intra-scanner variability in quantitative DCE-MRI (qDCE) measurement remains a concern. We developed a point-of-care portable perfusion phantom (P4) that can be imaged with a human subject in a standard MRI scanner to detect and correct the inter/intra-scanner variability of qDCE measurement. We demonstrated that the PDAC response to chemotherapy could be accurately assessed using quantitative DCE-MRI after our P4-based error correction method approximately seven weeks after starting therapy in two clinics.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords